Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
- PMID: 12475782
- DOI: 10.2337/diabetes.51.2007.s394
Regulation of pancreatic beta-cell glucokinase: from basics to therapeutics
Abstract
Glucokinase (GK) serves as glucose sensor in pancreatic beta-cells and in other glucose sensor cells in the body. Biochemical genetic studies have characterized many activating and inactivating GK mutants that have been discovered in patients with hyperinsulinemic hypoglycemia or diabetes, all inherited as autosomal dominant traits. Mathematical modeling of the kinetic data of recombinant human wild-type and mutant GK accurately predicts the effects of GK mutations on the threshold of glucose-stimulated insulin release and glucose homeostasis. Structure/function studies of the enzyme suggest the existence of a hitherto unknown allosteric activator site of the enzyme that has significant implications for the physiological chemistry of GK-containing cells, particularly the pancreatic beta-cells. Glucose is the preeminent positive regulator of beta-cell GK expression and involves molecular mechanisms that are still to be elucidated in detail, but seem to have a specific requirement for increased glucose metabolism. Pharmaceutical chemists, motivated by the clear tenets of the GK glucose-sensor paradigm, have searched for and have discovered a novel class of GK activator molecules. The therapeutic application of this basic discovery offers a new principle for drug therapy of diabetes.
Similar articles
-
Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).Biochem J. 1999 Sep 1;342 ( Pt 2)(Pt 2):345-52. Biochem J. 1999. PMID: 10455021 Free PMC article.
-
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.Handb Exp Pharmacol. 2011;(203):357-401. doi: 10.1007/978-3-642-17214-4_15. Handb Exp Pharmacol. 2011. PMID: 21484579 Review.
-
Glucokinase and glucose homeostasis: proven concepts and new ideas.Biochem Soc Trans. 2005 Feb;33(Pt 1):306-10. doi: 10.1042/BST0330306. Biochem Soc Trans. 2005. PMID: 15667334
-
Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.Diabetes. 1999 Aug;48(8):1645-51. doi: 10.2337/diabetes.48.8.1645. Diabetes. 1999. PMID: 10426385
-
Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm.Diabetes. 1996 Feb;45(2):223-41. doi: 10.2337/diab.45.2.223. Diabetes. 1996. PMID: 8549869 Review.
Cited by
-
Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production.Biomolecules. 2022 Feb 20;12(2):335. doi: 10.3390/biom12020335. Biomolecules. 2022. PMID: 35204835 Free PMC article. Review.
-
New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice.Biochim Biophys Acta. 2014 Dec;1842(12 Pt B):2593-600. doi: 10.1016/j.bbadis.2014.06.023. Epub 2014 Jun 27. Biochim Biophys Acta. 2014. PMID: 24980705 Free PMC article. Review.
-
Maturity Onset Diabetes of the Young-New Approaches for Disease Modelling.Int J Mol Sci. 2021 Jul 14;22(14):7553. doi: 10.3390/ijms22147553. Int J Mol Sci. 2021. PMID: 34299172 Free PMC article. Review.
-
The Association between Pediatric NAFLD and Common Genetic Variants.Children (Basel). 2017 Jun 18;4(6):49. doi: 10.3390/children4060049. Children (Basel). 2017. PMID: 28629152 Free PMC article. Review.
-
GCK-MODY (MODY 2) Caused by a Novel p.Phe330Ser Mutation.ISRN Pediatr. 2011;2011:676549. doi: 10.5402/2011/676549. Epub 2011 Apr 26. ISRN Pediatr. 2011. PMID: 22389783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
